当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 现金流量表

灵康药业

(603669)

  

流通市值:39.75亿  总市值:39.75亿
流通股本:7.12亿   总股本:7.12亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金246,221,143.6469,321,072.75371,605,687.42256,887,980.39
  收到其他与经营活动有关的现金12,321,428.974,643,390.2531,529,453.6421,602,442.4
  经营活动现金流入小计258,542,572.6173,964,463403,135,141.06278,490,422.79
  购买商品、接受劳务支付的现金175,780,726.6355,829,571.63255,757,641.14200,079,495.71
  支付给职工以及为职工支付的现金19,448,777.2511,397,042.844,884,098.3135,762,503.92
  支付的各项税费9,401,358.086,566,882.2515,241,611.7213,202,906.94
  支付其他与经营活动有关的现金68,113,107.329,404,665.42220,116,875.65147,498,149.13
  经营活动现金流出小计272,743,969.26103,198,162.1536,000,226.82396,543,055.7
  经营活动产生的现金流量净额-14,201,396.65-29,233,699.1-132,865,085.76-118,052,632.91
二、投资活动产生的现金流量:
  收回投资收到的现金--9,697,845.189,689,834.21
  取得投资收益收到的现金--1,105,526.311,114,006.21
  处置固定资产、无形资产和其他长期资产收回的现金净额100,000100,0007,008,973.979,457,504.85
  收到的其他与投资活动有关的现金5,000,000-17,332,76217,332,762
  投资活动现金流入小计5,100,000100,00035,145,107.4637,594,107.27
  购建固定资产、无形资产和其他长期资产支付的现金2,030,506.231,921,1602,683,196.081,024,744.02
  投资活动现金流出小计2,030,506.231,921,1602,683,196.081,024,744.02
  投资活动产生的现金流量净额3,069,493.77-1,821,16032,461,911.3836,569,363.25
三、筹资活动产生的现金流量:
  取得借款收到的现金20,000,00020,000,00015,000,0005,000,000
  收到其他与筹资活动有关的现金386,001,713.451,713.45250,000,000252,008,404.39
  筹资活动现金流入小计406,001,713.4520,001,713.45265,000,000257,008,404.39
  偿还债务支付的现金1,000,000--1,008.25
  分配股利、利润或偿付利息支付的现金298,555.58130,722.236,591,341.08-
  支付其他与筹资活动有关的现金386,000,000-252,067,443.33250,000,000
  筹资活动现金流出小计387,298,555.58130,722.23258,658,784.41250,001,008.25
  筹资活动产生的现金流量净额18,703,157.8719,870,991.226,341,215.597,007,396.14
五、现金及现金等价物净增加额7,571,254.99-11,183,867.88-94,061,958.79-74,475,873.52
  加:期初现金及现金等价物余额153,207,461.73153,207,461.73247,269,420.52247,269,420.52
  期末现金及现金等价物余额160,778,716.72142,023,593.85153,207,461.73172,793,547
补充资料:
  净利润21,112,693.34--193,239,351.39-
  资产减值准备87,913.95-41,449,843.73-
  固定资产和投资性房地产折旧11,302,114.27-23,805,420.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,302,114.27-23,805,420.43-
  无形资产摊销3,532,107.67-7,260,712.26-
  长期待摊费用摊销1,370,214.06-3,505,953.31-
  处置固定资产、无形资产和其他长期资产的损失-82,662.06--3,533,141.93-
  固定资产报废损失1,959.29-818,869.01-
  公允价值变动损失4,012,230.84-570,782.06-
  财务费用10,949,533.78-21,197,524.07-
  投资损失505,778.54-2,407,842.88-
  递延所得税-232,533.64--465,067.31-
    递延所得税负债增加-232,533.64--465,067.31-
  存货的减少8,127,747.81--59,641,231.71-
  经营性应收项目的减少-48,780,015.93-6,317,605.54-
  经营性应付项目的增加-33,582,196.07--26,007,310.57-
  其他-112,311.82-41,741,183.73-
  现金的期末余额160,778,716.72-153,207,461.73-
  减:现金的期初余额153,207,461.73-247,269,420.52-
  现金及现金等价物的净增加额7,571,254.99--94,061,958.79-
公告日期2026-08-152026-04-292026-04-292025-10-31
审计意见(境内)标准无保留意见
TOP↑